These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7750805)

  • 1. Alpha-lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats.
    Maitra I; Serbinova E; Trischler H; Packer L
    Free Radic Biol Med; 1995 Apr; 18(4):823-9. PubMed ID: 7750805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats.
    Maitra I; Serbinova E; Tritschler HJ; Packer L
    Biochem Biophys Res Commun; 1996 Apr; 221(2):422-9. PubMed ID: 8619871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide.
    Carey JW; Pinarci EY; Penugonda S; Karacal H; Ercal N
    Free Radic Biol Med; 2011 Mar; 50(6):722-9. PubMed ID: 21172425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage.
    Mårtensson J; Steinherz R; Jain A; Meister A
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8727-31. PubMed ID: 2813421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin.
    Abe M; Reiter RJ; Orhii PB; Hara M; Poeggeler B
    J Pineal Res; 1994 Sep; 17(2):94-100. PubMed ID: 7869232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts.
    Packer L
    Ann N Y Acad Sci; 1994 Nov; 738():257-64. PubMed ID: 7832436
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection from hyperbaric oxidant stress by administration of buthionine sulfoximine.
    Komadina KH; Duncan CA; Bryan CL; Jenkinson SG
    J Appl Physiol (1985); 1991 Jul; 71(1):352-8. PubMed ID: 1680846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of mouse buthionine sulfoximine cataracts in vitro is inhibited by thiols or ascorbate.
    Calvin HI; Zhu G; Wu J; Banerjee U; Fu JS
    Exp Eye Res; 1997 Sep; 65(3):341-7. PubMed ID: 9299171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buthionine sulfoximine reduces the protective capacity of myocytes to withstand peroxide-derived free radical attack.
    Le CT; Hollaar L; van der Valk EJ; van der Laarse A
    J Mol Cell Cardiol; 1993 May; 25(5):519-28. PubMed ID: 8104252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin.
    Li ZR; Reiter RJ; Fujimori O; Oh CS; Duan YP
    J Pineal Res; 1997 Apr; 22(3):117-23. PubMed ID: 9213264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buthionine sulfoximine-induced glutathione depletion. Its effect on antioxidants, lipid peroxidation and calcium homeostasis in the lung.
    Thanislass J; Raveendran M; Devaraj H
    Biochem Pharmacol; 1995 Jul; 50(2):229-34. PubMed ID: 7632167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice.
    Calvin HI; Medvedovsky C; Worgul BV
    Science; 1986 Aug; 233(4763):553-5. PubMed ID: 3726547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
    Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
    Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects.
    Mãrtensson J; Meister A
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4656-60. PubMed ID: 2052548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants.
    Han D; Sen CK; Roy S; Kobayashi MS; Tritschler HJ; Packer L
    Am J Physiol; 1997 Nov; 273(5):R1771-8. PubMed ID: 9374822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of L-homocysteic acid and buthionine sulphoximine-mediated neurotoxicity in rat embryonic neuronal cultures with alpha-lipoic acid enantiomers.
    Lockhart B; Jones C; Cuisinier C; Villain N; Peyroulan D; Lestage P
    Brain Res; 2000 Feb; 855(2):292-7. PubMed ID: 10677603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress.
    Mårtensson J; Jain A; Stole E; Frayer W; Auld PA; Meister A
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9360-4. PubMed ID: 1681551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lens GSH depletion and electrolyte changes preceding cataracts induced by buthionine sulfoximine in suckling mice.
    Calvin HI; von Hagen S; Hess JL; Patel SA; Fu SC
    Exp Eye Res; 1992 Apr; 54(4):621-6. PubMed ID: 1623947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).
    Griffith OW; Meister A
    J Biol Chem; 1979 Aug; 254(16):7558-60. PubMed ID: 38242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of in utero administration of buthionine sulfoximine on rat development.
    Reyes E; Ott S; Robinson B; Contreras R
    Pharmacol Biochem Behav; 1995 Apr; 50(4):491-7. PubMed ID: 7617692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.